Cargando…

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection

SIMPLE SUMMARY: KRAS mutational heterogeneity between primary colorectal cancer and liver metastases may present a challenge in assessing prognostic information prior to the multimodal treatment. Aim of our study is to assess the incidence of KRAS discordance in a single-center series by comparing p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ardito, Francesco, Razionale, Francesco, Salvatore, Lisa, Cenci, Tonia, Vellone, Maria, Basso, Michele, Panettieri, Elena, Calegari, Maria Alessandra, Tortora, Giampaolo, Martini, Maurizio, Giuliante, Felice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125529/ https://www.ncbi.nlm.nih.gov/pubmed/33946899 http://dx.doi.org/10.3390/cancers13092148

Ejemplares similares

The Impact of KRAS Mutational Status on Long-Term Survival following Liver Resection for Hilar Cholangiocarcinoma
por: Ardito, Francesco, et al.
Publicado: (2022)

Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile?
por: Langella, Serena, et al.
Publicado: (2019)

Impairment of hepatocellular excretory function, sepsis and liver insufficiency after liver resection
por: Chiarla, Carlo, et al.
Publicado: (2014)

The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
por: Basso, Michele, et al.
Publicado: (2020)

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
por: Basso, Michele, et al.
Publicado: (2016)

Bile duct injury after cholecystectomy: timing of surgical repair should be based on clinical presentation. The experience of a tertiary referral center with Hepp-Couinaud hepatico-jejunostomy
por: Giuliante, Felice, et al.
Publicado: (2023)

Serum uric acid, creatinine, and the assessment of antioxidant capacity in critical illness
por: Giovannini, Ivo, et al.
Publicado: (2006)

Parenteral Nutrition in Liver Resection
por: Chiarla, Carlo, et al.
Publicado: (2012)

Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection
por: Ardito, Francesco, et al.
Publicado: (2022)

Pancreatico-Jejunostomy On Isolated Loop After Pancreatico-Duodenectomy: Is It Worthwhile?
por: Clemente, Gennaro, et al.
Publicado: (2022)

Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
por: Lucchetti, Donatella, et al.
Publicado: (2021)

High Arterial Lactate Levels after Hepatic Resection Are Associated with Low Oxygen Delivery and Predict Severe Postoperative Complications
por: Gaspari, Rita, et al.
Publicado: (2022)

Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
por: Orlandi, Armando, et al.
Publicado: (2021)

c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors
por: Strippoli, Antonia, et al.
Publicado: (2020)

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
por: Basso, M, et al.
Publicado: (2013)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
por: Zurlo, Ina Valeria, et al.
Publicado: (2021)

Peroral-cholangioscopy to plan surgery for protruding biliary lesions: report of four cases
por: Tringali, Andrea, et al.
Publicado: (2022)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target
por: Salvatore, Lisa, et al.
Publicado: (2019)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)
por: Calegari, Maria Alessandra, et al.
Publicado: (2021)

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
por: Zurlo, Ina Valeria, et al.
Publicado: (2020)

ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas
por: Orlandi, A., et al.
Publicado: (2015)

Mirizzi Syndrome: Diagnosis and Management of a Challenging Biliary Disease
por: Clemente, Gennaro, et al.
Publicado: (2018)

A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants
por: Giacò, Luciano, et al.
Publicado: (2022)

Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry
por: Giuliante, Felice, et al.
Publicado: (2021)

Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
por: Salvatore, Lisa, et al.
Publicado: (2023)

Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study
por: Grande, Giuseppe, et al.
Publicado: (2019)

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021)

Management of single pulmonary metastases from colorectal cancer: State of the art
por: Chiappetta, Marco, et al.
Publicado: (2022)

KRAS Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?
por: Morató, Olga, et al.
Publicado: (2022)

HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection
por: Abbate, Valeria, et al.
Publicado: (2017)

Extra-Neural Metastases of Late Recurrent Myxopapillary Ependymoma to Left Lumbar Paravertebral Muscles: Case Report and Review of the Literature
por: Mastantuoni, Ciro, et al.
Publicado: (2022)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

Acquired hemophagocytic syndrome: comment to the case report
por: Ciccarese, Chiara, et al.
Publicado: (2015)

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation
por: Ieni, Antonio, et al.
Publicado: (2014)

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
por: Vauthey, J-N, et al.
Publicado: (2012)

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
por: Barone, C, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3u2mi8oheu4jsmddgcne3ptn6o